Among the issues AdvaMed lobbied on were accountable care organizations, regulation of implantable devices, FDA approval and regulation of medical devices, and patents and trademarks.
AdvaMed reduced its spending by about 3 percent from the second quarter of 2010, when it spent about $379,000 on lobbying.
Related Articles on AdvaMed:
Key Business Groups Join Medical Device Industry in Opposing Tax
Study: Medical Device Spending Rising at Half the Rate of U.S. Inflation
Devicemakers Ask Congress to Ease Regulatory Burdens on Industry
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
